PIPPIN MEDICAL LTD 16201016 false 2025-01-22 2026-01-31 2026-01-31 The principal activity of the company is specialist medical activities Digita Accounts Production Advanced 6.30.9574.0 true 16201016 2025-01-22 2026-01-31 16201016 2026-01-31 16201016 core:CurrentFinancialInstruments core:WithinOneYear 2026-01-31 16201016 bus:Micro-entities 2025-01-22 2026-01-31 16201016 bus:AuditExemptWithAccountantsReport 2025-01-22 2026-01-31 16201016 bus:FullAccounts 2025-01-22 2026-01-31 16201016 bus:SmallCompaniesRegimeForAccounts 2025-01-22 2026-01-31 16201016 bus:RegisteredOffice 2025-01-22 2026-01-31 16201016 bus:Director1 2025-01-22 2026-01-31 16201016 bus:Director2 2025-01-22 2026-01-31 16201016 bus:PrivateLimitedCompanyLtd 2025-01-22 2026-01-31 16201016 bus:Agent1 2025-01-22 2026-01-31 16201016 countries:England 2025-01-22 2026-01-31 iso4217:GBP xbrli:pure

Registration number: 16201016

PIPPIN MEDICAL LTD

Annual Report and Unaudited Financial Statements

for the Period from 22 January 2025 to 31 January 2026

 

PIPPIN MEDICAL LTD

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

2

 

PIPPIN MEDICAL LTD

Company Information

Directors

Dr Greer

Mr Johnson

Registered office

16 Townsend
Almondsbury
Bristol
BS32 4EN

Accountants

hcl chartered accountants 32 Henbury Road
Westbury-on-Trym
Bristol
BS9 3NQ

 

PIPPIN MEDICAL LTD

(Registration number: 16201016)
Balance Sheet as at 31 January 2026

2026
£

Current assets

5,837

Creditors: Amounts falling due within one year

(3,133)

Total assets less current liabilities

2,704

Accruals and deferred income

(650)

 

2,054

Capital and reserves

2,054

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
16 Townsend
Almondsbury
Bristol
BS32 4EN

These financial statements were authorised for issue by the Board on 18 August 2026.

2

Staff numbers

The average number of persons employed by the company (including directors) during the period, was 2.

For the financial period ending 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the micro entities regime and FRS 105 ‘The Financial Reporting Standard Applicable to the Micro-entities Regime.

Approved and authorised by the Board on 18 August 2026 and signed on its behalf by:
 

.........................................
Dr Greer
Director